SPDL1 and renal cell carcinoma: In the present study, we also revealed that RCC patients with high serum levels of sPD-L1 had a shorter survival time compared to patients with low levels, which adds further support for a potential value of sPD-L1 as an additional tool in future prognostic implication in RCC.